On May 4, 2023, the Florida Legislature passed HB 387 expanding the use of telehealth for medical marijuana recertification. Once signed by Florida Governor, Ron Desantis, the new law will become effective July 1, 2023.
The law does not change
Health Care Law Today
Health Care Law Today, published by Foley & Lardner LLP, focuses on legal developments and regulatory issues affecting the healthcare industry. The blog covers topics such as digital health investment trends, telehealth privacy and security best practices, Medicare policy changes including behavioral health service expansions, remote patient monitoring regulations, and compliance with state vaccination requirements for healthcare facilities. It addresses the intersection of healthcare delivery, technology, and law, providing updates on federal and state regulations, reimbursement policies, and risk management strategies relevant to healthcare providers, payers, and investors.
Latest from Health Care Law Today - Page 7
Florida’s Bill Targeting Gender Affirming Care Impacts Minors and Adults
On May 4, 2023, SB 254 passed the Florida Senate by a safe majority vote of 83 to 28 and is now on Governor DeSantis’s desk for approval. Once signed (expected shortly) , this law will take immediate effect and…
The Role of AI in Health Care M&A: Driving Value in a Difficult Market
Health care merger and acquisition (M&A) activity reached a significant level in 2022, even if not matching 2021’s record-breaking standard. This reflects the overall economy’s holding pattern in which resources are still being deployed strategically, but not at full throttle.…
FDA Encourages the Use of Decentralized Clinical Trials in New Draft Guidance
On May 2, 2023, the U.S. Food and Drug Administration (FDA) released Draft Guidance regarding the implementation of Decentralized Clinical Trials (DCTs) for drugs, biological products, and devices.
What is a Decentralized Clinical Trial?
DCTs are clinical trials where some…
Medicare Advantage: 2023 Final Rule Focuses on Social Determinants of Health and Utilization Review
Finalizing most of the provisions of a proposed rule (Proposed Rule) issued in December 2022,1 the Centers for Medicare & Medicaid Services (CMS) issued a massive rule (Final Rule)2 amending regulations for Medicare Advantage (MA or Part C), Medicare Cost Plan,…
Medicare Advantage and Part D Final Rule Affects Marketing and Sales Landscape for Not Only MA Plans and PD Sponsors, but also TPMOs and FDRs
In a prior article, my colleagues Judith Waltz and Alexandra Shalom summarized the takeaways related to health equity and utilization management provisions from the Centers for Medicare and Medicaid Services (CMS) Final Rule that amended regulations for Medicare Advantage…
Payor/Provider Convergence and What It Means for You
Editor’s Note: We are excited to announce that this article is the first of a series addressing the intersection of payor/provider convergence and the issues that plague insurance and health companies, payors, and providers. We will be addressing various considerations…
Collusion & Competition: What Antitrust Means for AI in Health Care
Health care companies are increasingly using artificial intelligence (AI) to create innovations, set prices, and compete with rivals. At the same time, federal and state antitrust enforcers are finding new ways to apply antitrust law to the modern, data-driven economy.…
What FQHCs Need to Know About Telehealth After the PHE
The Tax Man Cometh: Tax Perils in Physician Recapitalization Transactions
Physician recapitalization transactions are complex by nature and often present myriad issues. At Foley, in our representation of both investors in, and sellers of, physician practices, we note how often tax issues become gating items that drive the structural aspects…